A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages.

Pazhayattil AB, Sayeed-Desta N, Chen S, Ingram M

Open source

DOI
10.5731/pdajpst.2019.010173
Published
2020 Jul-Aug
Container
PDA journal of pharmaceutical science and technology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5731/pdajpst.2019.010173,
  title = {A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages.},
  author = {Pazhayattil AB and Sayeed-Desta N and Chen S and Ingram M},
  year = {2020},
  journal = {PDA journal of pharmaceutical science and technology},
  doi = {10.5731/pdajpst.2019.010173},
  url = {https://doi.org/10.5731/pdajpst.2019.010173}
}

RIS

TY  - JOUR
TI  - A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages.
AU  - Pazhayattil AB
AU  - Sayeed-Desta N
AU  - Chen S
AU  - Ingram M
PY  - 2020
JO  - PDA journal of pharmaceutical science and technology
DO  - 10.5731/pdajpst.2019.010173
UR  - https://doi.org/10.5731/pdajpst.2019.010173
ER  - 

APA

AB, P., N, S., S, C., & M, I. (2020). A Semiquantitative Risk Assessment Methodology Fit for Biopharmaceutical Life Cycle Stages.. PDA journal of pharmaceutical science and technology. https://doi.org/10.5731/pdajpst.2019.010173

Source records